Skip to main content

Study M060

Study name

Liu ML 2015

Title

Severe disturbance of glucose metabolism in peripheral blood mononuclear cells of schizophrenia patients: a targeted metabolomic study

Overall design

The aim of the present study was to characterize the alternations of glucose metabolites and identify potential diagnostic biomarkers for schizophrenia and major depression. Gas chromatography/mass spectrometry based targeted metabolomic method was used to quantify the levels of 13 glucose metabolites in peripheral blood mononuclear cells (PBMCs) derived from two groups (n = 55 for each group): (1) control group, (2) depressed group. The training set included 35 participants for each group, and the test set included 20 participants for each group.

Study Type

Type1;

Data available

Unavailable

Organism

Human;

Categories of depression

Depressive disorder; Depression; Depression;

Criteria for depression

DSM-IV-TR diagnosed MDD

Sample size

110

Tissue

Peripheral; Blood; Peripheral blood mononuclear cell;

Platform

MS-based; GC-MS: Agilent 7890A GC system with Agilent 5975 mass selective detector (Agilent Technologies Inc., USA);

PMID

26169624

DOI

10.1186/s12967-015-0540-y

Citation

Liu ML, Zhang XT, Du XY, et al. Severe disturbance of glucose metabolism in peripheral blood mononuclear cells of schizophrenia patients: a targeted metabolomic study. J Transl Med 2015;13:226.

Metabolite

Succinic acid;

Fructose 6-phosphate;

Dihydroxyacetone phosphate;